Abstract:Viral hepatitis can result in important morbidity and mortality, with its impact on health conditioned by the specific type of hepatitis, the geographical region of presentation and the development and access to new drugs, among other factors. Most acute presentation forms are self-limiting and may even go unnoticed, with just a small percentage of cases leading to acute liver failure that may necessitate transplantation or even cause the death of the patient. However, when they become chronic, as in the case of hepatitis B virus and C virus, unless they are diagnosed and treated adequately they may have severe consequences, like cirrhosis or hepatocarcinoma. Understanding of the mechanisms of transmission, the pathogenesis, the presence of vaccinations and the development over recent years of new highly-efficient, potent drugs have meant that we are now faced with a new scenario in the management of viral hepatitis, particularly hepatitis B virus and hepatitis C virus. The spectacular advances in hepatitis C virus treatment have led the World Health Organization to propose the objective of its eradication by 2030. The key aspect to achieving this goal is to ensure that these treatments reach all the more vulnerable population groups, in whom the different types of viral hepatitis have a high prevalence and constitute a niche that may perpetuate infection and hinder its eradication. Accordingly, micro-elimination programs assume special relevance at the present time.

Editorial: Diagnosis, Treatment and Prognosis of Viral Hepatitis, Volume II.

[Research Advances in Diagnosis and Treatment of Liver Failure in 2016].

Advances in Hepatitis B Treatment

Realm of hepatitis E: Challenges and opportunities.

Liver Diseases in COVID-19: Etiology, Treatment and Prognosis

Editorial: Considerations for Expanding Treatment in Grey Zone Chronic Hepatitis B Patients-Authors' Reply.

Liver diseases in COVID-19: Etiology, treatment and prognosis.

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B—difficult but necessary

Current treatment of chronic hepatitis B: Clinical aspects and future directions

Antiviral treatment standards for hepatitis B: An urgent need for expansion

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances

Evolution and diversity of the hepatitis B virus genome: Clinical implications

Hepatitis E:From behind the scenes to the front stage

New Insights into Hepatitis B Virus Biology and Implications for Novel Antiviral Strategies

[Clinical Cure of Hepatitis B: Consensus and Controversy].

Editorial: Epidemiology and Control of Hepatitis Viruses

Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application

The Laboratory Diagnosis of Viral Hepatitis in the Era of Antiviral Therapy

Present and future management of viral hepatitis

Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections